AstraZeneca PLC (BCBA:AZN)

Argentina flag Argentina · Delayed Price · Currency is ARS
51,300
-400 (-0.77%)
At close: Aug 14, 2025, 5:00 PM BRT
-3.02%
Market Cap 316.70T
Revenue (ttm) 67.33T
Net Income (ttm) 9.89T
Shares Out n/a
EPS (ttm) 6,326.07
PE Ratio 32.04
Forward PE 16.09
Dividend 834.84 (1.62%)
Ex-Dividend Date Aug 8, 2025
Volume 568
Average Volume 514
Open 51,650
Previous Close 51,700
Day's Range 51,050 - 51,850
52-Week Range 34,800 - 58,050
Beta n/a
RSI 67.17
Earnings Date Jul 29, 2025

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 94,300
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol AZN
Full Company Profile

Financial Performance

In 2024, AstraZeneca's revenue was $54.07 billion, an increase of 18.03% compared to the previous year's $45.81 billion. Earnings were $7.04 billion, an increase of 18.14%.

Financial numbers in USD Financial Statements

News

There is no news available yet.